FAKTOR-FAKTOR YANG MEMPENGARUHI KEPATUHAN PENGOBATAN PADA PASIEN TUBERCULOSIS (TB) MULTIDRUGS RESISTANT (MDR): LITERATURE REVIEW
Abstract
ABSTRAK
Latar Belakang : WHO memprediksi prevalensi TB MDR kurang lebih total kasus sebanyak 440.000 per tahun di dunia dan angka kematian yang cukup tinggi yaitu sekitar 150.000. Indonesia menduduki rangking ke 8 dari 27 negara–negara yang mempunyai beban tinggi dan prioritas kegiatan untuk TB MDR/XDR. Beban TB MDR di 27 negara ini menyumbang 85% dari beban TB MDR global. Kepatuhan pasien dalam melakukan pengobatan memegang peranan penting dalam keberhasilan pengobatan tuberkulosis karena dapat menimbulkan resistensi terhadap kuman tuberkulosis sehingga obat anti tuberkulosis (OAT) tidak dapat mencegah penyebaran penyakit tuberkulosis atau disebut Multi Drug Resistant Tuberculosis (MDR-TB).
TUJUAN : Tujuan dari literature review ini untuk menganalisis faktor-faktor yang mempengaruhi kepatuhan pengobatan pada pasien Tuberculosis (TB) Multidrugs Resistant (MDR).
METODE : Literatue ini menggunakan pencarian online menggunakan data base yang digunakan penulis antara lain yaitu PubMed, Wiley Online Library, Science Direct Google Schoolar dengan batasan tahun publikasi 5 tahun terakhir yaitu dari tahun 2015 sampai 2020. Kata kunci yang digunakan dalam pencarian literarut yaitu “Medication Adherence” AND “Tuberculosis MDR Patient” AND “faktors” AND “multi drugs resistant”.
HASIL : Penelusuran awal mendapatkan hasil artikel sejumlah 7.135 yang menunjukkan korelasi tinggi terhadap topik yang akan direview. Hasil akhir artikel yang memenuhi syarat sejumlah 14 artikel kemudian disintesis dan dikaji kualitasnya dengan tools yaitu Joanna Briggs Institute (JBI).
Kesimpulan : Faktor kepatuhan pengobatan pada literature yang sudah direview antara lain faktor lingkungan, faktor individu, faktor demografik, faktor interpersonal, faktor ekonomi.
Keywords
References
Alene, K. A., Viney, K., McBryde, E. S., Gray, D. J., Melku, M., & Clements, A. C. A. (2019). Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case–control study. Transboundary and Emerging Diseases, 66(4), 1611–1618. https://doi.org/10.1111/tbed.13188
Arnold, A., Cooke, G. S., Kon, O. M., Dedicoat, M., Lipman, M., Loyse, A., Butcher, P. D., Ster, I. C., & Harrison, T. S. (2017). Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008–2014. Journal of Infection, 74(3), 260–271. https://doi.org/10.1016/j.jinf.2016.12.005
Atif, M., Bashir, A., Ahmad, N., Fatima, R. K., Saba, S., & Scahill, S. (2017). Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients. BMC Infectious Diseases, 17(1), 1–12. https://doi.org/10.1186/s12879-017-2746-5
Baya, B., Achenbach, C. J., Kone, B., Toloba, Y., Dabitao, D. K., Diarra, B., Goita, D., Diabaté, S., Maiga, M., Soumare, D., Ouattara, K., Kanoute, T., Berthe, G., Kamia, Y. M., Sarro, Y. dit S., Sanogo, M., Togo, A. C. G., Dembele, B. P. P., Coulibaly, N., … Diallo, S. (2019). Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali. International Journal of Infectious Diseases, 81, 149–155. https://doi.org/10.1016/j.ijid.2019.02.004
Beda Ama, P. G., & Suhermi, S. (2020). Pengaruh Faktor Klinis Dan Keteraturan Minum Obat Dengan Terjadinya TB MDR di Wilayah Kerja Puskesmas Kecamatan Pasar Rebo Jakarta Timur. Jurnal Ilmiah Kesehatan, 12(1), 15–27. https://doi.org/10.37012/jik.v12i1.115
Buston, E. (2019). Treatment Compliance TB Patients with The Event of MDR TB In MDR TB Polyclinic RSUD Dr . M . Yunus Bengkulu. 14, 54–57.
Desissa, F., Workineh, T., & Beyene, T. (2018). Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. BMC Public Health, 18(1), 1–6. https://doi.org/10.1186/s12889-018-5371-3
Dheda, K., Cox, H., Esmail, A., Wasserman, S., Chang, K. C., & Lange, C. (2018). Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? Respirology, 23(1), 36–45. https://doi.org/10.1111/resp.13143
Fregona, G., Cosme, L. B., Moreira, C. M. M., Bussular, J. L., Dettoni, V. do V., Dalcolmo, M. P., Zandonade, E., & Maciel, E. L. N. (2017). Risk factors associated with multidrug-resistant tuberculosis in Espírito Santo, Brazil. Revista de Saude Publica, 51, 41. https://doi.org/10.1590/S1518-8787.2017051006688
Ibrahim, E., Baess, A. I., & Al Messery, M. A. (2017). Pattern of prevalence, risk factors and treatment outcomes among Egyptian patients with multidrug resistant tuberculosis. Egyptian Journal of Chest Diseases and Tuberculosis, 66(3), 405–411. https://doi.org/10.1016/j.ejcdt.2016.11.002
Kassa, G. M., Teferra, A. S., Wolde, H. F., Muluneh, A. G., & Merid, M. W. (2019). Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: A retrospective follow-up study. BMC Infectious Diseases, 19(1), 1–11. https://doi.org/10.1186/s12879-019-4447-8
Khan, I., Ahmad, N., Khan, S., Muhammad, S., Ahmad Khan, S., Ahmad, I., Khan, A., Gulalai, & Atif, M. (2019). Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan. Journal of Infection and Public Health, 12(6), 809–815. https://doi.org/10.1016/j.jiph.2019.04.009
Lange, C., Alghamdi, W. A., Al-Shaer, M. H., Brighenti, S., Diacon, A. H., DiNardo, A. R., Grobbel, H. P., Gröschel, M. I., von Groote-Bidlingmaier, F., Hauptmann, M., Heyckendorf, J., Köhler, N., Kohl, T. A., Merker, M., Niemann, S., Peloquin, C. A., Reimann, M., Schaible, U. E., Schaub, D., … Schön, T. (2018). Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. Journal of Internal Medicine, 284(2), 163–188. https://doi.org/10.1111/joim.12780
Mesfin, E. A., Beyene, D., Tesfaye, A., Admasu, A., Addise, D., Amare, M., Dagne, B., Yaregal, Z., Tesfaye, E., & Tessema, B. (2018). Drug-resistance patterns of mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS ONE, 13(6), 1–16. https://doi.org/10.1371/journal.pone.0197737
Muvunyi, C. M., Ngabonziza, J. C. S., Uwimana, I., Harelimana, J. D. D., Mucyo, Y., Sebatunzi, O. R., Muvunyi, T. Z., Seruyange, E., Masaisa, F., Mazarati, J. B., & Gasana, M. (2019). Highly successful treatment outcome of multidrug-resistant and genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains in Rwanda. Tropical Medicine and International Health, 24(7), 879–887. https://doi.org/10.1111/tmi.13245
Okethwangu, D., Birungi, D., Biribawa, C., Kwesiga, B., Turyahabwe, S., Ario, A. R., & Zhu, B. P. (2019). Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013-2017. BMC Infectious Diseases, 19(1), 1–10. https://doi.org/10.1186/s12879-019-4014-3
Parmar, M. M., Sachdeva, K. S., Dewan, P. K., Rade, K., Nair, S. A., Pant, R., & Khaparde, S. D. (2018). Unacceptable treatment outcomes and associated factors among India’s initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007–2011): Evidence leading to policy enhancement. PLoS ONE, 13(4), 1–24. https://doi.org/10.1371/journal.pone.0193903
Ramlall, S., Lessells, R. J., Naidu, T., Sandra Mthembu, S., Padayatchi, N., Burns, J. K., & Tomita, A. (2020). Neurocognitive functioning in MDR-TB patients with and without HIV in KwaZulu-Natal, South Africa. Tropical Medicine and International Health, 25(8), 919–927. https://doi.org/10.1111/tmi.13444
Rumende, C. M. (2018). Risk Factors for Multidrug-resistant Tuberculosis. 50(1), 1–2.
Stosic, M., Vukovic, D., Babic, D., Antonijevic, G., Foley, K. L., Vujcic, I., & Grujicic, S. S. (2018a). Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: A case-control study. BMC Public Health, 18(1), 1–8. https://doi.org/10.1186/s12889-018-6021-5
Stosic, M., Vukovic, D., Babic, D., Antonijevic, G., Foley, K. L., Vujcic, I., & Grujicic, S. S. (2018b). Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: A case-control study. BMC Public Health, 18(1), 91–96. https://doi.org/10.1186/s12889-018-6021-5
Woimo, T. T., Yimer, W. K., Bati, T., & Gesesew, H. A. (2017). The prevalence and factors associated for multidrugs resistant tuberculosis treatment non-adherence among pulmonary tuberculosis patients in public health care facilities in South Ethiopia: a cross-sectional study. BMC Public Health, 17(1), 1–10. https://doi.org/10.1186/s12889-017-4188-9
DOI: https://doi.org/10.33859/dksm.v15i1.930
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Rizaluddin Akbar
This work is licensed under a Creative Commons Attribution 4.0 International License.